Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other
companies in this sector in Taiwan:
Johnson Chemical Pharmaceutical Works Co Ltd
sales of 411.91 million Taiwanese Dollars [US$13.73 million]
TSH Biopharm Corp Limited
(515.65 million Taiwanese Dollars [US$17.19 million]
of which 100%
was Drug and Chemical), and
Sagittarius Life Science Corp.
(411.41 million Taiwanese Dollars [US$13.72 million]
of which 96%
was Non-toxic sector).
During the year ended December of 2018, sales at
Genovate Biotechnology Co., Limited were 455.80 million Taiwanese Dollars (US$15.20 million).
increase of 11.6%
versus 2017, when the company's sales were 408.27 million Taiwanese Dollars.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
923.2% in 2018, from
177,000.00 Taiwanese Dollars to 1.81 million Taiwanese Dollars.
Genovate Biotechnology Co., Limited also saw significant increases in sales in
Agency (up 87.6% to 15.19 million Taiwanese Dollars)
Not all segments of Genovate Biotechnology Co., Limited experienced an increase in sales in 2018:
sales of Technical Service fell 35.1% to 12.03 million Taiwanese Dollars.
(However, this segment's sales were only a very small portion of the company's overall sales).